Key facts
- It has raised $580K; the latest was Early Stage VC in Aug 2025.
- Notable investors include Tech Incubator Program for Startup, Korea Development Bank, Korea Investment Accelerator, J Curve Investment, KAIST Venture Investment Holdings — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for MetaDx
- ·The full record, as it builds
Funding rounds
No funding rounds for MetaDx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MetaDx
Developer of veterinary diagnostic systems designed to improve the efficiency and accuracy of pet healthcare. The company's platform leverages artificial intelligence to analyze various biological markers, predict anesthesia emergencies, and detect early signs of cancer in pets, enabling veterinarians to make informed decisions, optimize treatment plans, and provide an optimal quality of life for both pets and their owners.
- Sector
- Information Technology
- HQ
- Seoul, South Korea
- Founded
- 2024
- Employees
- 12
- Website
- metadxlab.com/
- Ownership
- Privately Held (backing)
MetaDx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MetaDx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MetaDx in its N-PORT filings yet. We sweep new filings monthly.